QR-Code

Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance

<b>Background/Objectives</b>: 5α-Reductase inhibitors (5ARIs) are commonly used to treat and prevent androgenic alopecia and benign prostatic hyperplasia. Despite their well-established effectiveness, they are associated with adverse drug reactions (ADRs), highlighting the need for continuous safety...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Ricardo Alves, Samuel Silvestre, Cristina Monteiro
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2026-06-01
Schriftenreihe:Pharmaceuticals
Schlagworte:
5α-reductase
dutasteride
finasteride
benign prostatic hyperplasia
androgenic alopecia
pharmacovigilance
Online-Zugang:https://www.mdpi.com/1424-8247/19/6/939
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge